ARB

69 drugs in development·37 companies·1 clinical trial

Drug Pipeline by Phase

Approved(25)

Drug	Company
candesartan cilexetil	Aptinyx Inc. (APTX)
carbamazepine	ANI PHARMACEUTICALS INC (ANIP)
carboprost	ANI PHARMACEUTICALS INC (ANIP)
carboprost	DR REDDYS LABORATORIES LTD (RDY)
exforge	Novartis AG (NVS)
exforge hct	Novartis AG (NVS)
GOCOVRI	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
inbrija	Acorda Therapeutics, Inc. (ACOR)
lamotrigine	Teva Pharmaceutical Industries Limited (TEVA)
losartan	Teva Pharmaceutical Industries Limited (TEVA)
losartan	Mylan II B.V. (MYL)
modeyso	Jazz Pharmaceuticals plc (JAZZ)
ojemda	Day One Biopharmaceuticals, Inc. (DAWN)
olpruva	Acer Therapeutics Inc. (ACER)
ONGENTYS	Amneal Pharmaceuticals, Inc. (AMRX)
oxcarbazepine	ANI PHARMACEUTICALS INC (ANIP)
RYTARY	Amneal Pharmaceuticals, Inc. (AMRX)
sevelamer carbonate	DR REDDYS LABORATORIES LTD (RDY)
sevelamer carbonate	Impax Laboratories, LLC (IPXL)
telmisartan	Inventiva S.A. (IVA)
Upstaza	PTC THERAPEUTICS, INC. (PTCT)
valsartan	Mylan II B.V. (MYL)
vyalev	AbbVie Inc. (ABBV)
XADAGO	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)

Phase 3(7)

Drug	Company
Enzalutamide	Merus N.V. (MRUS)
Fludrocortisone acetate	Merus N.V. (MRUS)
hmpl-306	HUTCHMED (China) Ltd (HMDCF)
Mercaptopurine Oral Suspension	Filana Therapeutics Inc. (FLNA)
New Formulation of Niraparib and Abiraterone Acetate	Merus N.V. (MRUS)
Procarbazine Hydrochloride	Filana Therapeutics Inc. (FLNA)
sul-dur	Entasis Therapeutics Holdings Inc. (ETTX)

Phase 2(14)

Drug	Company
Abiraterone acetate tablets	Merus N.V. (MRUS)
Afatinib Oral Tablet	Merus N.V. (MRUS)
Brentuximab Vedotin	UNITED THERAPEUTICS Corp (UTHR)
Dacarbazine	UNITED THERAPEUTICS Corp (UTHR)
Direct Oral Anticoagulant	Merus N.V. (MRUS)
Enfortumab vedotin	UNITED THERAPEUTICS Corp (UTHR)
Enzalutamide Pill	Merus N.V. (MRUS)
gomekli	SpringWorks Therapeutics, Inc. (SWTX)
Ibrutinib	ENANTA PHARMACEUTICALS INC (ENTA)
MCLA-128	Merus N.V. (MRUS)
MCLA-145	Merus N.V. (MRUS)
Olaparib Pill	Merus N.V. (MRUS)
Sapanisertib (CB-228, formerly TAK-228)	Calithera Biosciences, Inc. (CALA)
Vinblastine	UNITED THERAPEUTICS Corp (UTHR)

Phase 1(8)

Drug	Company
arq 751	ARQULE INC (ARQL)
elzovantinib	Turning Point Therapeutics, Inc. (TPTX)
idh305	NOVARTIS AG (NVSEF)
idh305	Novartis AG (NVS)
rVSV∆G-MARV-GP	Valneva SE (VALN)
tp-6076	TETRAPHASE PHARMACEUTICALS INC (TTPH)
tpx-0046	Turning Point Therapeutics, Inc. (TPTX)
Veliparib	Filana Therapeutics Inc. (FLNA)

Preclinical(4)

Drug	Company
mrtx1133	Mirati Therapeutics, Inc. (MRTX)
p-otc-101	Poseida Therapeutics, Inc. (PSTX)
pan-mutant pi3kα inhibitor	OnKure Therapeutics, Inc. (OKUR)
prx-otc	PHASERX, INC. (PZRX)

Unknown(2)

Drug	Company
acg-801	Aceragen, Inc. (ACGN)
opgx-lca5	Opus Genetics, Inc. (IRD)

N/A(2)

Drug	Company
First-line antihypertensive single-pill combination	Merus N.V. (MRUS)
Nano-crystalline megestrol acetate	Merus N.V. (MRUS)

Phase 1/Phase 2(4)

Drug	Company
brimarafenib	SpringWorks Therapeutics, Inc. (SWTX)
ecur-506	PRECISION BIOSCIENCES INC (DTIL)
envometinib	Immuneering Corp (IMRX)
opgx-best1	Opus Genetics, Inc. (IRD)

Phase 2/Phase 3(1)

Drug	Company
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)

Phase 4(2)

Drug	Company
Daunorubicin Hydrochloride	Filana Therapeutics Inc. (FLNA)
Ponatinib Hydrochloride	Filana Therapeutics Inc. (FLNA)

BioSniper tracks 69 drugs in development for ARB across 37 companies.

There are 1 clinical trial targeting ARB tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.